228672
Samarium(III) oxide
99.9% trace metals basis
Synonym(s):
Samaria
Sign Into View Organizational & Contract Pricing
All Photos(3)
About This Item
Recommended Products
Assay
99.9% trace metals basis
form
powder
reaction suitability
reagent type: catalyst
core: samarium
density
8.35 g/mL at 25 °C (lit.)
SMILES string
O=[Sm]O[Sm]=O
InChI
1S/3O.2Sm
InChI key
PRCWVHVINXAFRG-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Related Categories
Storage Class Code
10 - Combustible liquids
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Pharmaceutical research, 24(4), 695-704 (2007-03-21)
To develop a robust radiolabeling technique to enable evaluation of difficult to radiolabel gastric retentive formulations using gamma scintigraphy. The use of a successful radiolabel will allow accurate assessment of the gastric residence time of the formulations. The retention of
International journal of pharmaceutics, 281(1-2), 3-10 (2004-08-04)
This paper is a report from a pharmacoscintigraphic study with an Egalet constant-release system containing caffeine and natural abundance samarium oxide. First the formulation was tested in vitro to clarify integrity during irradiation in the nuclear reactor. Then six healthy
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 60(4), 933-939 (2004-03-24)
Microphone based photoacoustic (PA) spectrometer to study solids in powder form was designed and fabricated. Laser PA spectra of Sm3+ ion in Sm2O3 and SmCl3.6H2O microcrystalline powders were recorded first time in 484-542 nm spectral region at room temperature. Analysis
Journal of pharmaceutical sciences, 97(1), 225-236 (2007-08-28)
Treatment of systemic disease with phosphorothioate antisense oligonucleotides (PS ASOs) has been accomplished using local or parenteral routes of administration to date. This report describes, for the first time, the effective oral delivery of a second generation oligonucleotide where significant
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 8(3), 193-201 (1999-06-24)
The effect of the neutron activation factors, i.e., admixture of samarium oxide (Sm2O3) and irradiation time, on the physico-chemical properties of the raw materials and the in vitro dissolution and disintegration of hydrophilic and lipophilic suppositories was investigated. It was
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service